|
Remifentanil
for Awake Intubation
Techniques:
-
Establish
intravenous access and apply monitors, premedicate with 1-2
mg Midazolam if vitals are stable and patient can tolerate.
Glycoprolate or other anticholinergic will dry secretions to
facilitate onset of block (and possibly avoid bradycardia).
-
Establish
a pump for Remifentanil and start infusion at 0.05ug/kg/min
while continuing to observe patient's vital signs. Remifentanil's
rapid but gradual onset by infusion minimizes the risk of apnea.
Its short duration allows return of respiration after the infusion
is stopped. In addition, Naloxone allows prompt reversal of
opioid effects.
- The
patient should be placed in a semi-upright or sitting position
with firm support behind the head to avoid involuntary motor withdrawal.
In addition to sedation and analgesia, topicalization of the airway
is the second component to awake intubation.
-
Nasal airway is topicalized with cotton pledgetts soaked with
anesthetic solution and introduced through the nares along
the turbinates all the way to posterior end of nasal passage.
- Second
set of pledgetts is introduced with cephalad angulation
to follow middle turbinate back to mucosa overlying the
sphenoid bone to block the sphenopalatine ganglia branches.
Bilateral blockade of sphenopalatine nerve will also produce
posterior pharyngeal anesthesia.
- Allow
pledgett to remain in contact with mucosa for 2-3 minutes.
- 4%
cocaine solution has traditionally been the anesthetic
of choice due to its vasoconstrictive properties. Alternatives
today are 3-4% Lidocaine with 0.25-0.5% Phenylephrine
or 1:200,000 Epinephrine.
- The
posterior pharynx is topicalized with commercial spray or
atomizer with 4% Lidocaine (high concentration of local anesthetic
is required to penetrate mucosal membranes).
- First
stage is to spray the tongue with local anesthetics and
ask the patient to gargle and swallow the residual liquid
in the mouth.
- Second
stage is to further introduce local anesthetic by gradually
applying additional agent using a tongue blade to open
the mouth and test areas that have become anesthetized.
Alternately, one can apply 5% Lidocaine to a tongue blade
and have the patient enjoy it like a lollipop.
- Beware
of copious secretions, which decrease the effect of the
local anesthetics. Additionally, suction excess anesthetic
to avoid overdose.
- Superior
laryngeal nerve blockade, glossopharyngeal nerve blockade and
tracheal anesthesia are OPTIONAL in conjunction with Remifentanil.
(An informal poll among colleagues who utilize Remifentanil for
awake intubation indicates that they have never applied a needle
to patient's head and neck.) However, conditions for intubation
are optimal when local anesthetic is used.
- Superior
laryngeal nerve blockade:
-
Bilaterally identify the ala of thyroid cartilage (inferior
to posterior portion of hyoid bone on each side).
- Prepare
5 ml syringe of 1-2% Lidocaine with 23 gauge 1.75cm needle.
Retract the skin with index finger of one hand caudad
down over thyroid cartilage.
- Insert
needle until it rests on the superior margin of the cartilage.
- Pass
the needle through the thyroid membrane and aspirate.
- If
aspirate is negative, inject 2.5 ml of prepared solution
into the space below the membrane.
- Repeat
each step on the opposite side.
- Glossopharyngeal
nerve blockade:
- Retract
tongue medially with gloved finger; expose base of anterior
pillar.
- Insert
25 gauge (spinal) needle 0.5 cm subcutaneously, aspirate,
inject 2 ml of 1.5% lidocaine.
- Repeat
the above on the opposite side
-
Tracheal anesthesia:
- Raise
small skin wheal over cricothyroid membrane (optional).
- Gently
insert 20 gauge intravenous catheter with needle through
the wheal and cricothyroid membrane. (Or utilize a short
22-23 guage needle.)
- Aspirate
first (the aspirate should be air), remove the steel stylet
(needle), leave the plastic catheter in place.
- Attach
2-4 ml of 4% Lidocaine to the catheter (some add 1% Tetracaine
to mixture).
Spray the anesthetic solution during inspiration to allow
the liquid to travel distally. Patient usually coughs.
- If
anesthetic solution is injected while patient forcibly
exhales, the trachea, the larynx and the posterior pharynx
may be adequately anesthetized and the superior laryngeal
block is unnecessary.
- Insertion
of airway devices: LMA, Flexible/Rigid Fiberscope, Lightwand,
or Intubating LMA as described in previous sections.
References:
-
Egan
TD. "Remifentanil Pharmacokinetics and Pharmacodynamics.
A Preliminary Appraisal." Clin Pharmacokinet 29(1995),
pp80-94.
-
Reed
AP. "Preparation for Intubation of the Awake Patient."
Mt Sinai J Med 62(1995), pp10-20.
-
Amin
HM, Spochak AM, Esposito BF, et al. "Naloxone-induced and
Spontaneous Reversal of Depressed Ventilatory Responses to Hypoxia
During and After Continuous Infusion of Remifentanil or Alfentanil."
J Pharmacol Exp Ther 274(1995), pp34-39.
-
Barash
PG, et al. Clinical Anesthesia. 3rd Edition, Lippincott
William & Wilkins, 1996, pp676-678.
-
Gross
JB, et al. "A Suitable Substitute for 4% Cocaine Before
Blind Nasotracheal Intubation: 3% Lidocaine-0.25% Phenylephrine
Nasal Spray." Anesth Analog 63(1984), p915.
-
Egan
TD. "Remifentanil for Conscious Sedation and Analgesia
During Awake Fiberoptic Tracheal Intubation: A Case Report with
Pharmacokinetic Simulations." J Clin Anesth 11(1999),
pp64-68.
Mask Induction with Sevoflurane
Gradual induction:
- Best
for adult patients
- Enhanced
by nitrous oxide- 50-70%
- Patient
breathes with gradually increasing concentrations of Sevoflurane
- Adequate
anesthetic depth occurs in 60-90 seconds with a minimum inspired
concentration
of 7%
Single
breath induction (pediatric patients):
-
Best for pediatric patients
- Vital
capacity induction
- Prime
the circuit with 7.5-8% Sevoflurane
- Minimal
airway irritation
- Faster
induction than Halothane, Isoflurane, or Enflurane
Desflurane
with the Laryngeal Mask Airway
Techniques:
- After
induction and insertion of LMA, administer Desflurane anesthesia
at gradually increasing concentrations.
- Maintain
adequate depth for surgical stimulation.
- Allow
spontaneous or controlled ventilation as needed for the procedure.
- Reverse
muscle relaxants before allowing return of spontaneous ventilation.
- Provide
appropriate analgesia before emergence.
- Discontinue
Desflurane at the end of the case.
- Remove
LMA when the patient opens mouth to command or demonstrates return
of airway reflexes.
|